Additionally, studies have reported that TGF-β signaling mediated by Smad2/3 may be involved in OA progression by inducing the recruitment of MSCs and osteoprogenitors to the subchondral bone, ending with aberrant bone remodeling that initiates and worsens osteoarthritis. The gene discussed is SMAD2; the disease is osteoarthritis.